These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1601 related items for PubMed ID: 22661461
1. UPLC and LC-MS studies on degradation behavior of irinotecan hydrochloride and development of a validated stability-indicating ultra-performance liquid chromatographic method for determination of irinotecan hydrochloride and its impurities in pharmaceutical dosage forms. Kumar N, Sangeetha D, Reddy SP. J Chromatogr Sci; 2012 Oct; 50(9):810-9. PubMed ID: 22661461 [Abstract] [Full Text] [Related]
9. Development and validation of a novel stability-indicating HPLC method for the quantitative determination of eleven related substances in ezetimibe drug substance and drug product. Luo Z, Deng Z, Liu Y, Wang G, Yang W, Hou C, Tang M, Yang R, Zhou H. Talanta; 2015 Jul 01; 139():67-74. PubMed ID: 25882410 [Abstract] [Full Text] [Related]
11. A Stability-Indicating UPLC Method for the Determination of Potential Impurities and Its Mass by a New QDa Mass Detector in Daclatasvir Drug Used to Treat Hepatitis C Infection. Jagadabi V, Nagendra Kumar PV, Mahesh K, Pamidi S, Ramaprasad LA, Nagaraju D. J Chromatogr Sci; 2019 Jan 01; 57(1):44-53. PubMed ID: 30169761 [Abstract] [Full Text] [Related]
12. Analysis of duloxetine hydrochloride and its related compounds in pharmaceutical dosage forms and in vitro dissolution studies by stability indicating UPLC. Rao DD, Sait SS, Reddy AM, Chakole D, Reddy YR, Mukkanti K. J Chromatogr Sci; 2010 Nov 01; 48(10):819-24. PubMed ID: 21044412 [Abstract] [Full Text] [Related]
13. Development and validation of a stability-indicating RP-HPLC method for the simultaneous estimation of process related impurities and degradation products of rasagiline mesylate in pharmaceutical formulation. Reddy PS, Sudhakar Babu K, Kumar N. J Chromatogr Sci; 2013 Mar 01; 51(3):242-9. PubMed ID: 22988002 [Abstract] [Full Text] [Related]
17. Development of a stability-indicating UPLC method for determining olanzapine and its associated degradation products present in active pharmaceutical ingredients and pharmaceutical dosage forms. Krishnaiah Ch, Vishnu Murthy M, Kumar R, Mukkanti K. J Pharm Biomed Anal; 2011 Mar 25; 54(4):667-73. PubMed ID: 21075576 [Abstract] [Full Text] [Related]
20. Development and validation of a stability-indicating reverse phase ultra performance liquid chromatographic method for the estimation of nebivolol impurities in active pharmaceutical ingredients and pharmaceutical formulation. Thummala VR, Lanka MK. Se Pu; 2015 Oct 25; 33(10):1051-8. PubMed ID: 26930962 [Abstract] [Full Text] [Related] Page: [Next] [New Search]